174 related articles for article (PubMed ID: 21701492)
61. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.
Lucas DM; Edwards RB; Lozanski G; West DA; Shin JD; Vargo MA; Davis ME; Rozewski DM; Johnson AJ; Su BN; Goettl VM; Heerema NA; Lin TS; Lehman A; Zhang X; Jarjoura D; Newman DJ; Byrd JC; Kinghorn AD; Grever MR
Blood; 2009 May; 113(19):4656-66. PubMed ID: 19190247
[TBL] [Abstract][Full Text] [Related]
62. Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia.
Janes MR; Vu C; Mallya S; Shieh MP; Limon JJ; Li LS; Jessen KA; Martin MB; Ren P; Lilly MB; Sender LS; Liu Y; Rommel C; Fruman DA
Leukemia; 2013 Mar; 27(3):586-94. PubMed ID: 23090679
[TBL] [Abstract][Full Text] [Related]
63. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.
Morisot S; Wayne AS; Bohana-Kashtan O; Kaplan IM; Gocke CD; Hildreth R; Stetler-Stevenson M; Walker RL; Davis S; Meltzer PS; Wheelan SJ; Brown P; Jones RJ; Shultz LD; Civin CI
Leukemia; 2010 Nov; 24(11):1859-66. PubMed ID: 20739953
[TBL] [Abstract][Full Text] [Related]
64. The microtubule targeting agent PBOX-15 inhibits integrin-mediated cell adhesion and induces apoptosis in acute lymphoblastic leukaemia cells.
Lysaght J; Verma NK; Maginn EN; Ryan JM; Campiani G; Zisterer DM; Williams DC; Browne PV; Lawler MP; McElligott AM
Int J Oncol; 2013 Jan; 42(1):239-46. PubMed ID: 23135704
[TBL] [Abstract][Full Text] [Related]
65. Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia.
Randhawa S; Cho BS; Ghosh D; Sivina M; Koehrer S; Müschen M; Peled A; Davis RE; Konopleva M; Burger JA
Br J Haematol; 2016 Aug; 174(3):425-36. PubMed ID: 27071778
[TBL] [Abstract][Full Text] [Related]
66. Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.
Diamanti P; Cox CV; Moppett JP; Blair A
Blood; 2013 Feb; 121(8):1384-93. PubMed ID: 23264600
[TBL] [Abstract][Full Text] [Related]
67. Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model.
Hasan MN; Queudeville M; Trentin L; Eckhoff SM; Bronzini I; Palmi C; Barth T; Cazzaniga G; te Kronnie G; Debatin KM; Meyer LH
Oncotarget; 2015 Jan; 6(3):1382-95. PubMed ID: 25682198
[TBL] [Abstract][Full Text] [Related]
68. Effects of IL-7 on human lymphocytes.
Kim HS; Kang CM; Findley H; Ragab AH
J Korean Med Sci; 1993 Apr; 8(2):93-8. PubMed ID: 8397935
[TBL] [Abstract][Full Text] [Related]
69. SLAM family predicting the initiation potential of human acute lymphoblastic leukemia in NOD/SCID mice.
Wang N; Xiao F; Liu JP; Wang D; Geng Z; Wang J; Ma SY; Shu LL; Chen TP; Zhou JF; Huang L
Chin Med J (Engl); 2011 Oct; 124(19):3074-9. PubMed ID: 22040559
[TBL] [Abstract][Full Text] [Related]
70. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse.
Lock RB; Liem N; Farnsworth ML; Milross CG; Xue C; Tajbakhsh M; Haber M; Norris MD; Marshall GM; Rice AM
Blood; 2002 Jun; 99(11):4100-8. PubMed ID: 12010813
[TBL] [Abstract][Full Text] [Related]
71. Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts.
Jones L; McCalmont H; Evans K; Mayoh C; Kurmasheva RT; Billups CA; Houghton PJ; Smith MA; Lock RB
Pediatr Blood Cancer; 2019 Aug; 66(8):e27765. PubMed ID: 31012549
[TBL] [Abstract][Full Text] [Related]
72. Extensive alternative splicing of interleukin-7 in malignant hematopoietic cells: implication of distinct isoforms in modulating IL-7 activity.
Korte A; Möricke A; Beyermann B; Köchling J; Taube T; Kebelmann-Betzing C; Henze G; Seeger K
J Interferon Cytokine Res; 1999 May; 19(5):495-503. PubMed ID: 10386862
[TBL] [Abstract][Full Text] [Related]
73. β-Arrestin1 promotes the self-renewal of the leukemia-initiating cell-enriched subpopulation in B-lineage acute lymphoblastic leukemia related to DNMT1 activity.
Shu Y; Zhou X; Qi X; Liu S; Li K; Tan J; Liu Z; Yu J; Zhang P; Zou L
Cancer Lett; 2015 Feb; 357(1):170-178. PubMed ID: 25444908
[TBL] [Abstract][Full Text] [Related]
74. Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia.
Swaminathan S; Klemm L; Park E; Papaemmanuil E; Ford A; Kweon SM; Trageser D; Hasselfeld B; Henke N; Mooster J; Geng H; Schwarz K; Kogan SC; Casellas R; Schatz DG; Lieber MR; Greaves MF; Müschen M
Nat Immunol; 2015 Jul; 16(7):766-774. PubMed ID: 25985233
[TBL] [Abstract][Full Text] [Related]
75. The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis.
Ito C; Tecchio C; Coustan-Smith E; Suzuki T; Behm FG; Raimondi SC; Pui CH; Campana D
Leukemia; 2002 Jul; 16(7):1344-52. PubMed ID: 12094259
[TBL] [Abstract][Full Text] [Related]
76. CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule.
Uckun FM; Qazi S; Ma H; Reaman GH; Mitchell LG
Integr Biol (Camb); 2015 Feb; 7(2):237-49. PubMed ID: 25567759
[TBL] [Abstract][Full Text] [Related]
77. Low IL-23 levels in peripheral blood and bone marrow at diagnosis of acute leukemia in children increased with the elimination of leukemic burden.
Zampogiannis A; Piperi C; Baka M; Zoi I; Papavassiliou AG; Moschovi M
J Cell Mol Med; 2021 Aug; 25(15):7426-7435. PubMed ID: 34235838
[TBL] [Abstract][Full Text] [Related]
78. T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7.
Buffière A; Uzan B; Aucagne R; Hermetet F; Mas M; Nassurdine S; Aznague A; Carmignac V; Tournier B; Bouchot O; Ballerini P; Barata JT; Bastie JN; Delva L; Pflumio F; Quéré R
Oncogene; 2019 Nov; 38(48):7357-7365. PubMed ID: 31417180
[TBL] [Abstract][Full Text] [Related]
79. Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins.
Weston-Bell NJ; Hendriks D; Sugiyarto G; Bos NA; Kluin-Nelemans HC; Forconi F; Sahota SS
Leukemia; 2013 Jan; 27(1):241-5. PubMed ID: 22705994
[No Abstract] [Full Text] [Related]
80. Expression and effect of serum interleukin-24 level on bone marrow mononuclear cells in children with acute leukemia.
Cheng HR; Wu BQ; Chen L; Zhang ZX; Li B
Genet Mol Res; 2015 Dec; 14(4):17281-8. PubMed ID: 26681222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
